Transgene SA
PAR:TNG
Transgene SA
PAR:TNG
Price:
1.328 EUR
-0.6%
Market Closed
Updated:
May 17, 2024
Transgene SA
Cash from Financing Activities
|
Transgene SA
Cash from Financing Activities Peer Comparison
Comparables:
VLA
NANO
IPH
ALCLS
ABVX
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Transgene SA
PAR:TNG
|
Cash from Financing Activities
€11.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-14%
|
|
|
Valneva SE
PAR:VLA
|
Cash from Financing Activities
€63.1m
|
CAGR 3-Years
43%
|
CAGR 5-Years
15%
|
CAGR 10-Years
6%
|
|
|
Nanobiotix SA
PAR:NANO
|
Cash from Financing Activities
€46.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Innate Pharma SA
PAR:IPH
|
Cash from Financing Activities
-€2m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cellectis SA
PAR:ALCLS
|
Cash from Financing Activities
$82.9m
|
CAGR 3-Years
45%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
28%
|
|
|
Abivax SA
PAR:ABVX
|
Cash from Financing Activities
€335.3m
|
CAGR 3-Years
89%
|
CAGR 5-Years
99%
|
CAGR 10-Years
N/A
|
See Also
What is Transgene SA's Cash from Financing Activities?
Cash from Financing Activities
11.4m
EUR
11.4m
EUR
Based on the financial report for Dec 31, 2023, Transgene SA's Cash from Financing Activities amounts to 11.4m EUR.
What is Transgene SA's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-14%
-14%
The average annual Cash from Financing Activities growth rates for Transgene SA have been -9% over the past three years , -18% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
